Show
Sort by
-
Targeting hyperactive platelet-derived growth factor receptor-β signaling in T-cell acute lymphoblastic leukemia and lymphoma
-
- Journal Article
- A1
- open access
Pre-clinical evaluation of the hypomethylating agent decitabine for the treatment of T-cell lymphoblastic lymphoma
-
- Journal Article
- A1
- open access
Cyclin D2 overexpression drives B1a-derived MCL-like lymphoma in mice
-
The spleen as a sanctuary site for residual leukemic cells following ABT-199 monotherapy in ETP-ALL
-
- Journal Article
- A1
- open access
RUNX2 regulates leukemic cell metabolism and chemotaxis in high-risk T cell acute lymphoblastic leukemia
-
Targeting cytokine- and therapy-induced PIM1 activation in preclinical models of T-cell acute lymphoblastic leukemia and lymphoma
-
The EMT modulator SNAI1 contributes to AML pathogenesis via its interaction with LSD1
-
- Journal Article
- A1
- open access
Novel strategy for rapid functional in vivo validation of oncogenic drivers in haematological malignancies
-
Genetic characterization and therapeutic targeting of MYC-rearranged T cell acute lymphoblastic leukaemia
-
- Journal Article
- A1
- open access
Pre-clinical evaluation of second generation PIM inhibitors for the treatment of T-cell acute lymphoblastic leukemia and lymphoma